Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes through targeted T-cell activation.
THETFORD MINES, QC, Dec. 22, 2025 /CNW/ – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative ...
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...
The race for early cancer detection is one that physicians have been running for millennia. In one of humanity’s oldest surviving medical texts, the ancient Egyptian physician Imhotep described 46 ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
CAGR is driven by advancements in epigenetics research, methylation analysis technologies, and the rising need for ...
According to MarketsandMarkets, The report Next-generation Sequencing Services Market is projected to grow from USD 3.80 billion in 2025 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback